• CEO


We are conducting R&D and improving our research capacities by promoting open collaboration

Platform Technology

Possessing platform technologies for New Synthetic Drug

Ion Channel Platform(VITVO)
다음 내용 참조.
Library Screening Step for Discovery of Effective Substances(Hit)
Posses a library containing 100 thousand types of ion channels
High Throughput Screening(HTS) Discovery of Effective Substances (Hit)
Activation and Selectivity Evaluation Step
Manual Patch Clamp(Cellular Level)
MoA(Mechanism of Action) and Efficacy Evaluation Step
In vivo Patch Clamp(Animal Level)
Slide Patch Clamp(Tissue Level)
  • The Ion Channel Platform (VITVO) of MAXIPLUS MEDICAL & PHARMACEUTICAL Co., Ltd., is a platform that can evaluate efficacy at the cellular, tissue, or animal level to derive results rapidly through a highly efficient screening method.
  • In order to achieve clear interaction analysis of ion channels, electrophysiological assessment via a high-tech patch clamp is crucial.
  • The Ion Channel Platform (VITVO) can achieve 100 times higher efficacy through the auto-patch clamp method when compared with current manual patch clamp methods (which are able to evaluate 2 types in 1 week).